Altmetric
Adverse effects of tocilizumab versus baricitinib in severe COVID-19
| File | Description | Size | Format | |
|---|---|---|---|---|
 Letter to editor at CCM 4-7-23.docx | Accepted version | 66.07 kB | Microsoft Word | View/Open |
| Title: | Adverse effects of tocilizumab versus baricitinib in severe COVID-19 |
| Authors: | Leaf, DE Gordon, AC Lawler, PR |
| Item Type: | Journal Article |
| Issue Date: | 1-Sep-2023 |
| Date of Acceptance: | 1-Sep-2023 |
| URI: | http://hdl.handle.net/10044/1/106276 |
| DOI: | 10.1097/CCM.0000000000005933 |
| ISSN: | 0090-3493 |
| Publisher: | Lippincott, Williams & Wilkins |
| Start Page: | e184 |
| End Page: | e185 |
| Journal / Book Title: | Critical Care Medicine |
| Volume: | 51 |
| Issue: | 9 |
| Copyright Statement: | Copyright © 2023 Lippincott Williams & Wilkins, Inc. This is a non-final version of an article published in final form in Critical Care Medicine 51(9):p e184-e185, September 2023. | DOI: 10.1097/CCM.0000000000005933 |
| Publication Status: | Published |
| Conference Place: | United States |
| Online Publication Date: | 2023-09-01 |
| Appears in Collections: | Department of Surgery and Cancer Faculty of Medicine Imperial College London COVID-19 |